Commercial Credit Report for Vita 34 AG

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Vita 34 AG is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Vita 34 AG
Deutscher Platz 5a
Phone: +49 3414879240p:+49 3414879240	LEIPZIG, 04103 Germany	Ticker: V3VV3V

Business Summary

Vita 34 AG, formerly, Vita 34 International AG, is a Germany-based company operating in the medical technology sector and acts as a cell bank/stem cell bank. The Company is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. They also allow the growing of whole organs, such as the liver. On average, one out seven individuals, whose cells are stored, receives autologous stem cell transplant by the age of 70. The Company acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The Company operates in Germany, Spain, and Denmark.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
9/30/2024	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
8099	Health and allied services, not elsewhere classified
8731	Commercial physical and biological research

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Supervisory Board	AlexanderGranderath		12/15/2021	12/15/2021
Chairman of the Management Board, Chief Executive Officer	WolfgangKnirsch	62	1/1/2022	6/1/2016
Independent Deputy Chairman of the Supervisory Board	FlorianSchuhbauer	49	12/15/2021	7/1/2020
3 additional Officers and Directors records available in full report.

Business Names

Business Name
0NLV
Secuvita, S.L.
V3V
Vita 34 International AG

General Information

Number of Employees:	758	(As of 3/31/2024)
Outstanding Shares:	17,431,762	(As of 9/30/2024)
Stock Exchange:	ETR
Fax Number:	+49 3414879239
Email Address:	ir@vita34.de

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN